Janux Therapeutics (JANX) Q4 2024 Earnings

6NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.51
-0.38
-0.24
-0.11

Details

Expected EPS
-0.327325
Actual EPS
-0.51
Surprise EPS
-0.18
Surprise Percent
+55.81%

Description

Janux Therapeutics (JANX) has reported earnings of -0.51 per share for Q4 2024.

0 Comments

Share your thoughts